Jeffrey Moore
InvestorPresident at MC Healthcare Ventures
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
Dr. Jeff Moore joined MPH in 2008 with experience as a scientist, businessman, and investor, specializing in biochemistry, infectious disease, and immunology. He works closely with the firm's early-stage portfolio companies including F-star, Forge, and QurAlis.
Experience
- MP Healthcare Venture ManagementPresident & Board Member2008 — 2026Boston, Massachusetts, United States
- TRIMTECH Therapeutics LimitedBoard Member2026Cambridge, England, United Kingdom
- PharmEnableBoard Member2022 — 2026Cambridge, England, United Kingdom
- Outrun TherapeuticsBoard Member2021 — 2026
- Blacksmith MedicinesBoard Observer2021 — 2026
- CapsigenBoard Member2020 — 2026
- Ribometrix Inc.Board Observer2020 — 2026
- Sonde Health, Inc.Board Observer2020 — 2026
- Forge Therapeutics, Inc.Board Observer2017 — 2026
- Diamond Edge VenturesBoard Member2018 — 2025Menlo Park, CA
- SOLA BiosciencesBoard Member2021 — 2024Natick, Massachusetts, United States
- Korro Bio, Inc.Board Observer2020 — 2023
- F-star Therapeutics, Inc.Board Observer2009 — 2020
- QurAlisBoard Member2018 — 2020Cambridge, MA
- Thrasos Innovation Inc.Board Observer2012 — 2018
- Rigontec GmbHBoard Observer2015 — 2017
- miRagen Therapeutics, Inc.Board Observer2015 — 2017
- GenoceaBoard Observer2010 — 2014
- Intradigm CorporationBoard Observer2008 — 2010
- Covagen AGBoard Observer2009
Education
- MIT Sloan School of ManagementMBA - Sloan Fellow, Finance & Entrepreneurship2003 — 2004
- University of OxfordDPhil, Virology1990 — 1994
- Marine Biological LaboratoryBiology of Parasitism Summer Course1988
- UCLBiology and Immunology1985 — 1986
- University of New BrunswickBSc, Biology1982 — 1986
- EMBL
- Howard S. Billings
- MIT Sloan School of ManagementMaster of Business Administration, Finance
- Robert A Jobber
- University at AlbanyDoctor of Philosophy
Skills & more
FrenchEnglishSpanishSandConferencesPublic SpeakingWorkload PrioritizationStrategy9Strategic Planning4Target IdentificationEarly Stage InvestmentInvestment Decisions
+12 more
Reporting & AnalysisMilestonesGuitar PlayingMarketing ScienceProposal EvaluationDue DiligencePortfolio ManagementNASDAQStaff DevelopmentMedical DiagnosticsThird-Party Logistics (3PL)Investment StrategiesLanguages French · Spanish
From Jeffrey's professional profile.
Same school
Also attended MIT Sloan School of Management427
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor
+ 421 more
Also attended University of Oxford745
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 739 more
Also attended UCL272
André DuboisInvestor at Index VenturesFrédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire VenturesMarie FerriInvestor at DaphniElena PantaziPartner & Head of Platform at NorthzoneGiovanni MariggiInvestor at Medicxi
+ 266 more
Also attended University of New Brunswick8
Nelson SwitzerCo-Founder and Managing Partner at Climate Innovation CapitalNicole LeBlancAdvisory Committee at Nàdarra VenturesTarja WiklundInvestment Committee Member at Equivator®Kathryn LockhartBoard Member at Women's Equity LabLorna JohnsonBoard Member at Women's Equity LabHabib DableAdvisor at RA Capital
+ 2 more































